Profile | GDS5420 / 215393_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 402.71 | 64 |
GSM1296119 | B_lesional_pre-dose | 587.87 | 71 |
GSM1296076 | C_lesional_pre-dose | 281.4 | 59 |
GSM1296092 | D_lesional_pre-dose | 195.54 | 54 |
GSM1296103 | E_lesional_pre-dose | 649.77 | 72 |
GSM1296078 | F_lesional_pre-dose | 237.6 | 57 |
GSM1296107 | G_lesional_pre-dose | 796.17 | 76 |
GSM1296109 | H_lesional_pre-dose | 1124.33 | 81 |
GSM1296080 | I_lesional_pre-dose | 396.5 | 64 |
GSM1296090 | J_lesional_pre-dose | 234.15 | 56 |
GSM1296074 | K_lesional_pre-dose | 235.26 | 57 |
GSM1296111 | L_lesional_pre-dose | 945.57 | 78 |
GSM1296099 | M_lesional_pre-dose | 455.39 | 66 |
GSM1296086 | O_lesional_pre-dose | 168.61 | 51 |
GSM1296117 | P_lesional_pre-dose | 927.51 | 78 |
GSM1296113 | Q_lesional_pre-dose | 740.9 | 74 |
GSM1296096 | R_lesional_pre-dose | 437.54 | 65 |
GSM1296105 | S_lesional_pre-dose | 485.38 | 67 |
GSM1296098 | T_lesional_pre-dose | 493.07 | 67 |
GSM1296101 | U_lesional_pre-dose | 357.47 | 61 |
GSM1296121 | V_lesional_pre-dose | 745.85 | 75 |
GSM1296088 | W_lesional_pre-dose | 367.76 | 63 |
GSM1296082 | X_lesional_pre-dose | 260.27 | 58 |
GSM1296115 | Y_lesional_pre-dose | 918.1 | 78 |
GSM1296084 | Z_lesional_pre-dose | 295.83 | 59 |
GSM1296072 | B_lesional_day8 | 531.02 | 69 |
GSM1296069 | L_lesional_day8 | 674.65 | 73 |
GSM1296071 | P_lesional_day8 | 612.49 | 71 |
GSM1296070 | Y_lesional_day8 | 662.8 | 72 |
GSM1296073 | V_lesional_day8 | 486.48 | 68 |
GSM1296034 | A_lesional_day15 | 370.41 | 62 |
GSM1296041 | G_lesional_day15 | 1056.9 | 80 |
GSM1296035 | R_lesional_day15 | 237.06 | 55 |
GSM1296038 | U_lesional_day15 | 370.36 | 63 |
GSM1296047 | B_lesional_day15 | 480.57 | 67 |
GSM1296039 | E_lesional_day15 | 221.26 | 54 |
GSM1296042 | H_lesional_day15 | 597.4 | 71 |
GSM1296043 | L_lesional_day15 | 616.7 | 71 |
GSM1296037 | M_lesional_day15 | 237.78 | 55 |
GSM1296046 | P_lesional_day15 | 672.3 | 72 |
GSM1296044 | Q_lesional_day15 | 673.42 | 73 |
GSM1296045 | Y_lesional_day15 | 621.05 | 71 |
GSM1296025 | C_lesional_day15 | 381.65 | 63 |
GSM1296033 | D_lesional_day15 | 185.77 | 51 |
GSM1296027 | I_lesional_day15 | 142.67 | 49 |
GSM1296032 | J_lesional_day15 | 241.47 | 55 |
GSM1296024 | K_lesional_day15 | 185.43 | 52 |
GSM1296031 | W_lesional_day15 | 384.22 | 63 |
GSM1296028 | X_lesional_day15 | 214.53 | 54 |
GSM1296029 | Z_lesional_day15 | 218.05 | 54 |
GSM1296026 | F_lesional_day15 | 187.68 | 52 |
GSM1296030 | O_lesional_day15 | 154.44 | 50 |
GSM1296040 | S_lesional_day15 | 509.75 | 68 |
GSM1296036 | T_lesional_day15 | 585.18 | 70 |
GSM1296048 | V_lesional_day15 | 462.67 | 66 |
GSM1296059 | A_lesional_day43 | 271.16 | 58 |
GSM1296066 | G_lesional_day43 | 883.25 | 77 |
GSM1296060 | R_lesional_day43 | 238.49 | 55 |
GSM1296063 | U_lesional_day43 | 379.11 | 63 |
GSM1296064 | E_lesional_day43 | 360.81 | 63 |
GSM1296067 | H_lesional_day43 | 484.75 | 66 |
GSM1296062 | M_lesional_day43 | 372.99 | 62 |
GSM1296068 | Q_lesional_day43 | 556.84 | 69 |
GSM1296050 | C_lesional_day43 | 387.3 | 64 |
GSM1296057 | D_lesional_day43 | 185.68 | 51 |
GSM1296052 | I_lesional_day43 | 135.39 | 48 |
GSM1296054 | J_lesional_day43 | 269.68 | 56 |
GSM1296049 | K_lesional_day43 | 231.27 | 55 |
GSM1296055 | W_lesional_day43 | 312.63 | 59 |
GSM1296053 | X_lesional_day43 | 298.46 | 59 |
GSM1296058 | Z_lesional_day43 | 186.52 | 52 |
GSM1296051 | F_lesional_day43 | 285.1 | 59 |
GSM1296056 | O_lesional_day43 | 196.41 | 53 |
GSM1296065 | S_lesional_day43 | 311.88 | 59 |
GSM1296061 | T_lesional_day43 | 407.13 | 63 |
GSM1296095 | A_non-lesional_pre-dose | 264.85 | 57 |
GSM1296120 | B_non-lesional_pre-dose | 521.97 | 68 |
GSM1296077 | C_non-lesional_pre-dose | 325.16 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 405.4 | 63 |
GSM1296104 | E_non-lesional_pre-dose | 244.71 | 55 |
GSM1296079 | F_non-lesional_pre-dose | 388.07 | 64 |
GSM1296108 | G_non-lesional_pre-dose | 851.04 | 77 |
GSM1296110 | H_non-lesional_pre-dose | 691 | 73 |
GSM1296081 | I_non-lesional_pre-dose | 255.85 | 57 |
GSM1296091 | J_non-lesional_pre-dose | 132.56 | 47 |
GSM1296075 | K_non-lesional_pre-dose | 179.63 | 52 |
GSM1296112 | L_non-lesional_pre-dose | 939.26 | 79 |
GSM1296100 | M_non-lesional_pre-dose | 245.68 | 55 |
GSM1296087 | O_non-lesional_pre-dose | 148.46 | 50 |
GSM1296118 | P_non-lesional_pre-dose | 602.97 | 70 |
GSM1296114 | Q_non-lesional_pre-dose | 744.11 | 74 |
GSM1296097 | R_non-lesional_pre-dose | 253.37 | 56 |
GSM1296106 | S_non-lesional_pre-dose | 333.38 | 60 |
GSM1296102 | U_non-lesional_pre-dose | 264.94 | 56 |
GSM1296122 | V_non-lesional_pre-dose | 589.06 | 70 |
GSM1296089 | W_non-lesional_pre-dose | 262.89 | 56 |
GSM1296083 | X_non-lesional_pre-dose | 381.23 | 63 |
GSM1296116 | Y_non-lesional_pre-dose | 743.89 | 74 |
GSM1296085 | Z_non-lesional_pre-dose | 169.68 | 50 |